Directorate change

Summary by AI ^BETAClose X

Octagon Healthcare Funding plc announced directorate changes effective November 30, 2025, with David Robert Hardingham stepping down as alternate Director to Louis Javier Falero, representing Semperian PPP Investment Partners No.2 Limited. Neil Rae will assume this role as the new alternate Director to Louis Javier Falero on behalf of Semperian PPP Investment Partners No.2 Limited.

Disclaimer*

Octagon Healthcare Funding PLC

03 December 2025

Octagon Healthcare Funding plc

Directorate Change

In accordance with Listing Rule 9.6.11R, Octagon Healthcare Funding plc confirms the following directorate changes to the Board of Directors of Octagon Healthcare Funding plc, effective 30 November 2025:

David Robert Hardingham will step down from his role as alternate Director to Louis Javier Falero (on behalf of Semperian PPP Investment Partners No.2 Limited).

Neil Rae will be appointed to the role of alternate Director to Louis Javier Falero (on behalf of Semperian PPP Investment Partners No.2 Limited).

Enquiries:

Megan Cammidge

Email: megan.cammidge@semperian.co.uk

Phone: +442038697399

Mobile: +447304056012

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END